HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 436 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $907,322 | +49.5% | 7,973 | -18.6% | 0.01% | +42.9% |
Q3 2022 | $607,000 | -16.8% | 9,799 | +6.5% | 0.01% | -22.2% |
Q2 2022 | $730,000 | -38.2% | 9,203 | -17.8% | 0.01% | -30.8% |
Q1 2022 | $1,181,000 | +6.7% | 11,196 | +8.7% | 0.01% | +18.2% |
Q4 2021 | $1,107,000 | +0.2% | 10,301 | +1.9% | 0.01% | -8.3% |
Q3 2021 | $1,105,000 | -17.8% | 10,112 | -29.9% | 0.01% | -7.7% |
Q2 2021 | $1,344,000 | -4.9% | 14,428 | -6.1% | 0.01% | -18.8% |
Q1 2021 | $1,413,000 | +23.5% | 15,368 | -2.2% | 0.02% | +23.1% |
Q4 2020 | $1,144,000 | -2.9% | 15,721 | +2.9% | 0.01% | -18.8% |
Q3 2020 | $1,178,000 | +41.4% | 15,275 | +2.0% | 0.02% | +33.3% |
Q2 2020 | $833,000 | +65.6% | 14,979 | -12.3% | 0.01% | +71.4% |
Q1 2020 | $503,000 | +6.6% | 17,075 | +31.7% | 0.01% | +16.7% |
Q4 2019 | $472,000 | +12.9% | 12,963 | -16.0% | 0.01% | 0.0% |
Q3 2019 | $418,000 | +10350.0% | 15,436 | +8571.9% | 0.01% | – |
Q2 2019 | $4,000 | – | 178 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |